TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05142189: LuCa-MERIT-1: First-in-human, Open Label, Phase I Dose Confirmation Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Can

Sponsor: BioNTech SE · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 320 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$7,288,512

Rescue Site Savings

+$4,806,648

Unlock Full NCT05142189 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05142189 Rescue Dossier →